Supplementary Materials

Supplementary Material for:

High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy

Yan Ma, Julia Chapman, Mark Levine, Kishore Polireddy, Jeanne Drisko,* Qi Chen*

*Corresponding author. E-mail: qchen@kumc.edu (Q.C.); jdrisko@kumc.edu (J.D.).

Published 5 February 2014, Sci. Transl. Med. 6, 222ra18 (2014)
DOI: 10.1126/scitranslmed.3007154

This PDF file includes:

  • Fig. S1. Effects of PARP inhibitor and catalase on ascorbate-induced cytotoxicity in ovarian cancer cells.
  • Table S2. IC50 of ascorbate and carboplatin as single-drug or combination treatment.
  • Table S3. Number of patient encounters, adverse events, and duration of adverse event record.
  • Table S4. Number of patients showing adverse events in each category.

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Table S1. Original data (provided as an Excel file).

[Table S1]